COVID-19 infection increased the likelihood of death 3 months after stroke and reperfusion therapy seven times (OR 6.696; 95% CI 1.029–43.584), while hypoxemia, total WBC count, and CRP concentration were not significant predictors (Table 5). The gene discussed is CRP; the disease is stroke disorder.